scholarly journals Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors

2019 ◽  
Vol 9 ◽  
Author(s):  
Elena Poddubskaya ◽  
Alexey Bondarenko ◽  
Alexander Boroda ◽  
Evgenia Zotova ◽  
Alex Glusker ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Case ◽  
Lung Cancer Case ◽  
Targeted Therapeutics ◽  
Alk Inhibitors ◽  
Alk Positive

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case

2003 ◽  
Vol 21 (11) ◽  
pp. 2218-2220 ◽  
Author(s):  
Bharat L. Agrawal ◽  
Amaresh R. Nath ◽  
Thomas P. Glynn ◽  
David Velazco ◽  
Richard F. Garnett
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Cancer Case ◽  
Lung Cancer Case

scholarly journals P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients

2017 ◽  
Vol 12 (1) ◽  
pp. S1178-S1179
Author(s):  
Kazutoshi Komiya ◽  
Tomomi Nakamura ◽  
Yuki Kurihara ◽  
Haruki Hirakawa ◽  
Hironori Sadamatsu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Retrospective Analysis ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Alk Inhibitors ◽  
Lung Cancer Patients ◽  
Alk Positive

Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Lung Cancer ◽  
2019 ◽  
Vol 136 ◽  
pp. 109-114 ◽  
Author(s):  
Renaud Descourt ◽  
Maurice Perol ◽  
Gaëlle Rousseau-Bussac ◽  
David Planchard ◽  
Bertrand Mennecier ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Inhibitors ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document